BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND JAK2, ENSG00000096968, O60674, JTK10, 3717 AND Diagnosis
334 results:

  • 1. Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study.
    England JT; Szuber N; Sirhan S; Dunne T; Cerquozzi S; Hill M; Villeneuve PJA; Ho JM; Sadikovic B; Bhai P; Krishnan N; Dowhanik S; Hillis C; Capo-Chichi JM; Tsui H; Cheung V; Gauthier K; Sibai H; Davidson MB; Bankar A; Kotchetkov R; Gupta V; Maze D
    Leukemia; 2024 Mar; 38(3):570-578. PubMed ID: 38321107
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.
    Tefferi A; Vannucchi AM; Barbui T
    Am J Hematol; 2024 Apr; 99(4):697-718. PubMed ID: 38269572
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Atypical CML: diagnosis and treatment.
    Breccia M
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):476-482. PubMed ID: 38066919
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Clonal hematopoiesis and its evolution of myeloproliferative neoplasms].
    Zhang L; Dong H
    Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(45):3608-3614. PubMed ID: 38018059
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. T cell phenotype and lack of eosinophilia are not uncommon in extramedullary myeloid/lymphoid neoplasms with ETV6::FLT3 fusion: a case report and review of the literature.
    Schoelinck J; Gervasoni J; Guillermin Y; Beillard E; Pissaloux D; Chassagne-Clement C
    Virchows Arch; 2024 May; 484(5):853-857. PubMed ID: 37985498
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. DNMTs-mediated SOCS3 methylation promotes the occurrence and development of AML.
    Zhang X; Zhang K; Zhang J; Chang W; Zhao Y; Suo X
    Eur J Haematol; 2024 Mar; 112(3):439-449. PubMed ID: 37950514
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort.
    Metzgeroth G; Steiner L; Naumann N; Lübke J; Kreil S; Fabarius A; Haferlach C; Haferlach T; Hofmann WK; Cross NCP; Schwaab J; Reiter A
    Leukemia; 2023 Sep; 37(9):1860-1867. PubMed ID: 37454239
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management.
    Tefferi A; Barbui T
    Am J Hematol; 2023 Sep; 98(9):1465-1487. PubMed ID: 37357958
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Co-occurring mutations in ASXL1, SRSF2, and SETBP1 define a subset of myelodysplastic/ myeloproliferative neoplasm with neutrophilia.
    Jain T; Ware AD; Dalton WB; Pasca S; Tsai HL; Gocke CD; Gondek LP; Xian RR; Borowitz MJ; Levis MJ
    Leuk Res; 2023 Aug; 131():107345. PubMed ID: 37354804
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. FTIR- based serum structure analysis in molecular diagnostics of essential thrombocythemia disease.
    Guleken Z; Ceylan Z; Aday A; Bayrak AG; Hindilerden İY; Nalçacı M; Jakubczyk P; Jakubczyk D; Depciuch J
    J Photochem Photobiol B; 2023 Aug; 245():112734. PubMed ID: 37295134
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The international consensus classification of eosinophilic disorders and systemic mastocytosis.
    Wang SA; Orazi A; Gotlib J; Reiter A; Tzankov A; Hasserjian RP; Arber DA; Tefferi A
    Am J Hematol; 2023 Aug; 98(8):1286-1306. PubMed ID: 37283522
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Progression in Myeloid Neoplasms: Beyond the Myeloblast.
    Faria C; Tzankov A
    Pathobiology; 2024; 91(1):55-75. PubMed ID: 37232015
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. 'Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting.
    Gupta DG; Varma N; Sreedharanunni S; Abdulkadir SA; Naseem S; Sachdeva MUS; Binota J; Bose P; Malhotra P; Khadwal A; Varma S
    Br J Cancer; 2023 Jul; 129(1):143-152. PubMed ID: 37156894
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Prognostic analysis of children with Philadelphia chromosome-like acute lymphoblastic leukemia common genes].
    Hu WD; Li B; Su SF; Liu YF; Liu W; Zhang WL; Zuo WL; Yu RH
    Zhonghua Er Ke Za Zhi; 2023 May; 61(5):446-452. PubMed ID: 37096265
    [No Abstract]    [Full Text] [Related]  

  • 15. Advances in molecular evaluation of myeloproliferative neoplasms.
    Li N; Chen M; Yin CC
    Semin Diagn Pathol; 2023 May; 40(3):187-194. PubMed ID: 37087305
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. jak2/STAT5 Pathway Mutation Frequencies in South African BCR/ABL Negative MPN Patients.
    Shires KL; Rust AJ; Harryparsad R; Coburn JA; Gopie RE
    Hematol Oncol Stem Cell Ther; 2023 Apr; 16(3):291-302. PubMed ID: 37023224
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Cytological diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology.
    Combaluzier S; Quessada J; Abbou N; Arcani R; Tichadou A; Gabert J; Costello R; Loosveld M; Venton G; Berda-Haddad Y
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980287
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. De novo myeloid sarcoma mimicking gynecological tumors: a retrospective case series of eight patients.
    Gu Y; Zheng H; Mo S; Guo T; Chen L; Yang J; Xiang Y
    BMC Womens Health; 2023 Mar; 23(1):141. PubMed ID: 36978050
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A 68-Year-Old Man with a Cytogenetic diagnosis of Chronic Myeloid leukemia and Bone Marrow Findings of Philadelphia Chromosome Translocation Between the Long Arm of Chromosomes 9 and 22, Leading to the BCR-ABL1 Fusion Gene and V617F Mutation in the jak2 Gene.
    Warsi A; Alamoudi S; Alsuraihi AK; Althobaiti M; Daghistani M; Samarin K; Alahmadi MO; Abuyabis RG; Bogari RA; Filimban SA
    Am J Case Rep; 2023 Mar; 24():e938488. PubMed ID: 36864712
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Validation of the prognostic significance of the 2022 European leukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia.
    Lo MY; Tsai XC; Lin CC; Tien FM; Kuo YY; Lee WH; Peng YL; Liu MC; Tseng MH; Hsu CA; Chen JC; Lin LI; Sun HI; Chuang YK; Ko BS; Tang JL; Yao M; Chou WC; Hou HA; Tien HF
    Am J Hematol; 2023 May; 98(5):760-769. PubMed ID: 36861732
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 17.